Treatment of postmenopausal osteoporosis with odanacatib.
about
Novel biological markers of bone: from bone metabolism to bone physiologyStructural basis of collagen fiber degradation by cathepsin K.The safety and tolerability profile of therapies for the prevention and treatment of osteoporosis in postmenopausal women.Cathepsin K osteoporosis trials, pycnodysostosis and mouse deficiency models: Commonalities and differences.A novel approach to inhibit bone resorption: exosite inhibitors against cathepsin K
P2860
Treatment of postmenopausal osteoporosis with odanacatib.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Treatment of postmenopausal osteoporosis with odanacatib.
@ast
Treatment of postmenopausal osteoporosis with odanacatib.
@en
type
label
Treatment of postmenopausal osteoporosis with odanacatib.
@ast
Treatment of postmenopausal osteoporosis with odanacatib.
@en
prefLabel
Treatment of postmenopausal osteoporosis with odanacatib.
@ast
Treatment of postmenopausal osteoporosis with odanacatib.
@en
P2860
P1476
Treatment of postmenopausal osteoporosis with odanacatib.
@en
P2093
Roland D Chapurlat
P2860
P304
P356
10.1517/14656566.2014.881470
P407
P577
2014-01-24T00:00:00Z